Results 11 to 20 of about 31,387 (227)

Brazilian consensus in muscle-invasive and metastatic urothelial carcinoma

Brazilian Journal of Oncology, 2020
Urothelial carcinoma is a frequent worldwide malignancy. Poor survival rates in muscle-invasive and metastatic urothelial carcinoma impose major challenges for management.
Andrey Soares, Icaro Carvalho, Diogo Assed Bastos, Diogo Augusto Rodrigues da Rosa, Fernando Cotait Maluf, Ary Adamy, Daher Chade, Luis Felipe Piovesan, Allisson Bruno Barcelos Borges, Arthur Accioly, Lucas Nogueira   +10 more
doaj   +1 more source

Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy

Frontiers in Immunology, 2023
The treatment of metastatic urothelial carcinoma has dramatically changed over the past decade with the approval of several therapies from multiple drug classes including immune checkpoint inhibitors, targeted therapies, and antibody drug conjugates ...
David J. Benjamin, Robert Hsu
doaj   +1 more source

Unusual manifestations of secondary urothelial carcinoma

Human Pathology: Case Reports, 2016
High-grade papillary urothelial carcinoma regularly invades the bladder wall, adjacent prostate, seminal vesicles, ureters, vagina, rectum, retroperitoneum, and regional lymph nodes.
Chaohui Lisa Zhao, Rogers C. Griffith, Anna Ellermeier, Kammi Henriksen, Ali Amin   +4 more
doaj   +1 more source

Metastatic Urothelial Carcinoma of the Prepuce and Glans Penis: Suspected Implantation of Non-Muscle-Invasive Bladder Cancer via Urine

Case Reports in Oncology, 2014
Cutaneous metastatic implantation of non-muscle-invasive urothelial carcinoma via urine is a rare finding, and only few cases have been reported in the literature. Here, we present a case of metastatic urothelial carcinoma of the prepuce and glans penis,
Tomoyuki Makino, Yasuhide Kitagawa, Mikio Namiki   +2 more
doaj   +1 more source

Switch Maintenance Therapy for Metastatic Urothelial Carcinoma

Bladder Cancer, 2022
INTRODUCTION: While switch maintenance therapy is being increasingly investigated in solid tumors, it is a standard in only a few. We conducted a systematic review on switch maintenance therapy for metastatic urothelial carcinoma. EVIDENCE ACQUISITION: In this systematic review, we conducted a literature search in PubMed and Cochrane databases up to ...
Ahmed, Ramsha, Gupta, Shilpa
openaire   +2 more sources

Multiple cardiac metastases from urothelial carcinoma case report

The Egyptian Heart Journal, 2022
Background Cardiac metastases are rare and frequently remain undiagnosed due to the absence of clinical signs in the majority of cases. Malignancies found to most commonly metastasise to the heart include lung carcinoma, breast carcinoma and lymphoma ...
Neil Grech, William Camilleri, Alexander Borg   +2 more
doaj   +1 more source

Maintenance immunotherapy in advanced urothelial cancer

Gaceta Mexicana de Oncología, 2022
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-
María T. Bourlon, Nora Sobrevilla-Moreno   +1 more
doaj   +1 more source

Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis. [PDF]

Int J Cancer
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Niedersuess-Beke D, Mayrhofer K, Krauter J, Franke J, Vais D, Pallauf M, Kiesl D, Luger F, Pfuner J, Terbuch A, Bauernhofer T, Spielgelberg J, Banner A, Aufderklamm S, Wiesinger C, Schnabel S, Gampenrieder SP, Mühlmann J, Vallet S, Weibrecht S, Stoiber F, Andalibi H, Fajkovic H, Taghizadeh H, Miechowiecki J, Taedcke R, Heintel D, Shariat SF, Pichler M, Hilbe W, Pichler R.   +30 more
europepmc   +2 more sources

Low Grade Lymphoma Mimicking Metastatic Urothelial Carcinoma: When Do We Need Further Histologic Staging?

Case Reports in Oncological Medicine, 2016
Introduction. Patients with urothelial carcinoma of the bladder often present with metastases to regional lymph nodes, with lymphadenopathy on physical examination or radiographic imaging. Case Presentation. We present the case of a 73-year-old Caucasian
Azka Ali, William P. Skelton IV, Neeka N. Akhavan, Thu-Cuc Nguyen, Zachary A. Taylor, Tabitha Townsend, Prajwol Pathak, Nalini Hasija, Li Li, Jacqueline Indrisek, Scott Watson, Isis Nixon, Nam H. Dang, Robert Zlotecki, Paul Crispen, Robert Allan, Patricia Abbitt, Long H. Dang   +17 more
doaj   +1 more source

Androgen receptor in bladder cancer: A promising therapeutic target

Asian Journal of Urology, 2020
There has been a significant progress in the treatment of metastatic urothelial carcinoma in the last few years with the advent of immunotherapy after a long gap of no drug approvals for over 4 decades.
Abhishek Tripathi, Shilpa Gupta
doaj   +1 more source